Soluble pd-1 but not pd-l1 levels predict poor outcome in patients with high-risk diffuse large b-cell lymphoma

HIGHLIGHTS

• who: Heli Vajavaara et al. from the Research Program Unit, Applied Tumor Genomics Research Program, Faculty of Medicine, University of , Helsinki, Finland have published the article: Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma, in the Journal: Cancers 2021, x of /2021/
• what: The authors aimed to determine the clinical significance of PD-1 (sPD-1) and in patients with diffuse large B-cell lymphoma (DLBCL). The authors used serum samples collected during conduction of a prospective DLBCL trial at three different . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.